Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 790

1.

Multiple system atrophy and myoclonus: A morphologic marker in the spinal cord?

Kalia LV, Jellinger KA.

Neurology. 2019 Aug 13;93(7):287-288. doi: 10.1212/WNL.0000000000007941. No abstract available.

PMID:
31405931
2.

Traumatic brain injury and Alzheimer's disease neuropathology.

Jellinger KA.

Alzheimers Dement. 2019 Sep;15(9):1236-1237. doi: 10.1016/j.jalz.2019.06.3917. Epub 2019 Aug 8. No abstract available.

PMID:
31402325
3.

LATE to the PART-y.

Josephs KA, Mackenzie I, Frosch MP, Bigio EH, Neumann M, Arai T, Dugger BN, Ghetti B, Grossman M, Hasegawa M, Herrup K, Holton J, Jellinger K, Lashley T, McAleese KE, Parisi JE, Revesz T, Saito Y, Vonsattel JP, Whitwell JL, Wisniewski T, Hu W.

Brain. 2019 Sep 1;142(9):e47. doi: 10.1093/brain/awz224. No abstract available.

4.

Animal models of synucleinopathies and how they could impact future drug discovery and delivery efforts.

Jellinger KA.

Expert Opin Drug Discov. 2019 Oct;14(10):969-982. doi: 10.1080/17460441.2019.1638908. Epub 2019 Jul 5.

PMID:
31272236
5.

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Jellinger KA.

J Neural Transm (Vienna). 2019 Aug;126(8):997-1027. doi: 10.1007/s00702-019-02030-y. Epub 2019 Jun 24. Review.

PMID:
31236685
6.

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Jellinger KA.

J Neural Transm (Vienna). 2019 Aug;126(8):933-995. doi: 10.1007/s00702-019-02028-6. Epub 2019 Jun 18. Review.

PMID:
31214855
7.

L-dopa response pattern in a rat model of mild striatonigral degeneration.

Kaindlstorfer C, Stefanova N, Garcia J, Krismer F, Döbrössy M, Göbel G, Jellinger K, Granata R, Wenning GK.

PLoS One. 2019 Jun 10;14(6):e0218130. doi: 10.1371/journal.pone.0218130. eCollection 2019.

8.

TNFα inhibitors as targets for protective therapies in MSA: a viewpoint.

Ndayisaba A, Jellinger K, Berger T, Wenning GK.

J Neuroinflammation. 2019 Apr 11;16(1):80. doi: 10.1186/s12974-019-1477-5. Review.

9.

Primary age-related tauopathy (PART) and Alzheimer's disease (AD).

Jellinger KA.

Alzheimers Dement. 2019 May;15(5):720. doi: 10.1016/j.jalz.2019.01.005. Epub 2019 Mar 8. No abstract available.

PMID:
30853463
10.

Parkinsonism in MCI or mild Alzheimer's disease.

Jellinger KA.

Alzheimers Dement. 2019 Apr;15(4):598-599. doi: 10.1016/j.jalz.2018.12.014. Epub 2019 Mar 1. No abstract available.

PMID:
30827873
11.

Young-onset multiple system atrophy.

Jellinger KA.

Mov Disord. 2018 Dec;33(12):1974-1975. doi: 10.1002/mds.27567. No abstract available.

PMID:
30578693
12.

Different patterns of hippocampal tau pathology in Alzheimer's disease and PART.

Jellinger KA.

Acta Neuropathol. 2018 Nov;136(5):811-813. doi: 10.1007/s00401-018-1894-z. Epub 2018 Aug 7. No abstract available.

PMID:
30088091
13.

Very old onset parkinsonism: A clinical-pathological study.

Jellinger KA.

Parkinsonism Relat Disord. 2018 Dec;57:39-43. doi: 10.1016/j.parkreldis.2018.07.015. Epub 2018 Jul 24.

PMID:
30054179
14.

Is Braak staging valid for all types of Parkinson's disease?

Jellinger KA.

J Neural Transm (Vienna). 2019 Apr;126(4):423-431. doi: 10.1007/s00702-018-1898-9. Epub 2018 Jun 25. Review.

PMID:
29943229
15.

Lateralisation in Parkinson disease.

Riederer P, Jellinger KA, Kolber P, Hipp G, Sian-Hülsmann J, Krüger R.

Cell Tissue Res. 2018 Jul;373(1):297-312. doi: 10.1007/s00441-018-2832-z. Epub 2018 Apr 14. Review.

PMID:
29656343
16.

Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Jellinger KA, Korczyn AD.

BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.

17.

Proteomics for synaptic markers of cognitive decline in neurodegenerative diseases.

Attems J, Jellinger K.

Brain. 2018 Feb 1;141(2):329-331. doi: 10.1093/brain/awx360. No abstract available.

PMID:
29390123
18.

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.

Kaindlstorfer C, Jellinger KA, Eschlböck S, Stefanova N, Weiss G, Wenning GK.

J Alzheimers Dis. 2018;61(4):1253-1273. doi: 10.3233/JAD-170601. Review.

19.

Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Jellinger KA.

J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. Review.

PMID:
29222591
20.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut.

World J Biol Psychiatry. 2018 Jun;19(4):244-328. doi: 10.1080/15622975.2017.1375556. Epub 2017 Oct 27. Review.

21.

Brain monoamine oxidases in human parkinsonian disorders.

Jellinger KA.

Brain. 2017 Sep 1;140(9):2262-2264. doi: 10.1093/brain/awx190. No abstract available.

PMID:
29050396
22.

Potential clinical utility of multiple system atrophy biomarkers.

Jellinger KA.

Expert Rev Neurother. 2017 Dec;17(12):1189-1208. doi: 10.1080/14737175.2017.1392239. Epub 2017 Oct 23. Review.

PMID:
29023182
23.

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Jellinger KA.

J Alzheimers Dis. 2018;62(3):1141-1179. doi: 10.3233/JAD-170397. Review.

24.

Neuropathology of Nonmotor Symptoms of Parkinson's Disease.

Jellinger KA.

Int Rev Neurobiol. 2017;133:13-62. doi: 10.1016/bs.irn.2017.05.005. Epub 2017 Jun 27. Review.

PMID:
28802920
25.

The diabetic brain and cognition.

Riederer P, Korczyn AD, Ali SS, Bajenaru O, Choi MS, Chopp M, Dermanovic-Dobrota V, Grünblatt E, Jellinger KA, Kamal MA, Kamal W, Leszek J, Sheldrick-Michel TM, Mushtaq G, Meglic B, Natovich R, Pirtosek Z, Rakusa M, Salkovic-Petrisic M, Schmidt R, Schmitt A, Sridhar GR, Vécsei L, Wojszel ZB, Yaman H, Zhang ZG, Cukierman-Yaffe T.

J Neural Transm (Vienna). 2017 Nov;124(11):1431-1454. doi: 10.1007/s00702-017-1763-2. Epub 2017 Aug 1. Review.

PMID:
28766040
26.

Overlaps between multiple system atrophy and multiple sclerosis: A novel perspective.

Jellinger KA, Wenning GK.

Mov Disord. 2016 Dec;31(12):1767-1771. doi: 10.1002/mds.26870. Epub 2016 Nov 21. Review. No abstract available.

PMID:
27869324
27.

Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis.

Laukoter S, Rauschka H, Tröscher AR, Köck U, Saji E, Jellinger K, Lassmann H, Bauer J.

Acta Neuropathol. 2017 Apr;133(4):613-627. doi: 10.1007/s00401-016-1642-1. Epub 2016 Nov 5.

28.

Vascular depression consensus report - a critical update.

Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS, Meshandin IA, Mijajlovic MD, Niklewski G, Pospos S, Raju K, Richter K, Steffens DC, Taylor WD, Tene O.

BMC Med. 2016 Nov 3;14(1):161.

29.

Post-mortem assessment in vascular dementia: advances and aspirations.

McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kövari E, Love S, Popovic M, Skrobot O, Taipa R, Thal DR, Werring D, Wharton SB, Attems J.

BMC Med. 2016 Aug 26;14(1):129. doi: 10.1186/s12916-016-0676-5. Review.

30.

Adolf Hitler and his parkinsonism.

Jellinger KA.

Ann Indian Acad Neurol. 2016 Jul-Sep;19(3):419. doi: 10.4103/0972-2327.186856. No abstract available.

31.

Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.

Jellinger KA, Logroscino G, Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A.

Neurology. 2016 Jul 12;87(2):237-8. doi: 10.1212/WNL.0000000000002876. No abstract available.

PMID:
27402941
32.

Multiple system atrophy: pathogenic mechanisms and biomarkers.

Jellinger KA, Wenning GK.

J Neural Transm (Vienna). 2016 Jun;123(6):555-72. doi: 10.1007/s00702-016-1545-2. Epub 2016 Apr 20. Review.

PMID:
27098666
33.

Understanding Conflicting Neuropathological Findings.

Jellinger KA.

JAMA Neurol. 2016 Apr;73(4):479-80. doi: 10.1001/jamaneurol.2015.4879. No abstract available.

PMID:
26925877
34.

Erratum: Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

Love S, Chalmers K, Ince P, Esiri M, Attems J, Kalaria R, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG.

Am J Neurodegener Dis. 2015 Dec 28;4(2):49. eCollection 2015.

35.

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL 3rd, Wisniewski T, Woulfe JM, Yamada M, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):87-102. doi: 10.1007/s00401-015-1509-x. Epub 2015 Dec 10. Review.

36.

How close are we to revealing the etiology of Parkinson's disease?

Jellinger KA.

Expert Rev Neurother. 2015 Oct;15(10):1105-7. doi: 10.1586/14737175.2015.1079486. Epub 2015 Aug 17. No abstract available.

PMID:
26294223
37.

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.

Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG.

Neurobiol Dis. 2015 Aug;80:29-41. doi: 10.1016/j.nbd.2015.05.004. Epub 2015 May 15. Review.

PMID:
25982836
38.

Neuropathobiology of non-motor symptoms in Parkinson disease.

Jellinger KA.

J Neural Transm (Vienna). 2015 Oct;122(10):1429-40. doi: 10.1007/s00702-015-1405-5. Epub 2015 May 15. Review.

PMID:
25976432
39.

Olfaction and Aging: A Mini-Review.

Attems J, Walker L, Jellinger KA.

Gerontology. 2015;61(6):485-90. doi: 10.1159/000381619. Epub 2015 May 9. Review.

40.

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.

Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR Jr, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, Montine TJ, Nelson PT, Schmitt F, Schneider JA, Serrano-Pozo A, Thal DR, Toledo JB, Trojanowski JQ, Troncoso JC, Vonsattel JP, Wisniewski T.

Acta Neuropathol. 2015 May;129(5):757-62. doi: 10.1007/s00401-015-1407-2. Epub 2015 Mar 17. No abstract available.

41.

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.

Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J.

Acta Neuropathol. 2015 May;129(5):729-48. doi: 10.1007/s00401-015-1406-3. Epub 2015 Mar 11.

PMID:
25758940
42.

Diagnosis and differential diagnosis of MSA: boundary issues.

Kim HJ, Jeon BS, Jellinger KA.

J Neurol. 2015 Aug;262(8):1801-13. doi: 10.1007/s00415-015-7654-2. Epub 2015 Feb 7. Review.

PMID:
25663409
43.

Pathogenesis and treatment of vascular cognitive impairment.

Jellinger KA.

Neurodegener Dis Manag. 2014;4(6):471-90. doi: 10.2217/nmt.14.37. Review.

PMID:
25531689
44.

The cholinergic basal forebrain in Lewy body dementia and Alzheimer's disease.

Jellinger KA.

J Neurol. 2015 Feb;262(2):479-80. doi: 10.1007/s00415-014-7610-6. Epub 2014 Dec 12. No abstract available.

PMID:
25504308
45.

The overlap between vascular disease and Alzheimer's disease--lessons from pathology.

Attems J, Jellinger KA.

BMC Med. 2014 Nov 11;12:206. doi: 10.1186/s12916-014-0206-2. Review.

46.

Primary age-related tauopathy (PART): a common pathology associated with human aging.

Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT.

Acta Neuropathol. 2014 Dec;128(6):755-66. doi: 10.1007/s00401-014-1349-0. Epub 2014 Oct 28.

47.

Pathogenesis of mild parkinsonian signs in aging.

Jellinger KA.

J Neurol. 2015 Jan;262(1):213. doi: 10.1007/s00415-014-7546-x. Epub 2014 Oct 28. No abstract available.

PMID:
25346065
48.

Neuropathology of multiple system atrophy: new thoughts about pathogenesis.

Jellinger KA.

Mov Disord. 2014 Dec;29(14):1720-41. doi: 10.1002/mds.26052. Epub 2014 Oct 9. Review.

PMID:
25297524
49.

Challenges of multimorbidity of the aging brain: a critical update.

Jellinger KA, Attems J.

J Neural Transm (Vienna). 2015 Apr;122(4):505-21. doi: 10.1007/s00702-014-1288-x. Epub 2014 Aug 5. Review.

PMID:
25091618
50.

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies.

Krismer F, Jellinger KA, Scholz SW, Seppi K, Stefanova N, Antonini A, Poewe W, Wenning GK.

Parkinsonism Relat Disord. 2014 Aug;20(8):793-9. doi: 10.1016/j.parkreldis.2014.05.005. Epub 2014 May 21. Review.

Supplemental Content

Loading ...
Support Center